Previous section Next section
REGULATION OF GLYCOGENESIS
Body_ID: HC012009
page 165
0
page 166
Body_ID: P0166
Body_ID: P012033
Body_ID: F012006
Figure 12.6 Regulation of protein kinase A in muscle. Activation of glycogenolysis and glycolysis in muscle during exercise. PFK-1, phosphofructokinase-1.
Glycogenesis, and energy storage in general, occurs during and immediately following meals. GlucoseView drug information and other carbohydrates, rushing into the liver from the intestines via the portal circulation, are efficiently trapped to make glycogen. Excess glucoseView drug information proceeds to the peripheral circulation, where it is taken up into muscle and adipose tissue for energy reserves or storage. We normally eat sitting down, rather than during exercise, so that the opposing pathways of utilization and storage of energy are temporally compartmentalized functions in our lives. Energy storage is under the control of the polypeptide hormone insulin, which is stored in β-cells in the pancreatic islets of Langerhans. Insulin is secreted into blood following a meal, tracking blood glucoseView drug information concentration. It has two primary functions in carbohydrate metabolism: first, insulin reverses the actions of glucagon in phosphorylation of proteins, turning off glycogen phosphorylase and activating glycogen synthase, promoting glucoseView drug information storage; second, it stimulates the uptake of glucoseView drug information into muscle and adipose tissue, facilitating synthesis and storage of glycogen and triglycerides. Insulin also acts at the level of gene expression stimulating the synthesis of enzymes involved in carbohydrate metabolism and storage and conversion of glucoseView drug information into triglycerides.
Body_ID: P012032
page 166
0
page 167
Body_ID: P0167
Body_ID: P012035
Body_ID: F012007
Figure 12.7 Mechanisms of insulin action. Regulatory effects of insulin on hepatic and muscle carbohydrate metabolism. (See also Chapter 20.)
Protein tyrosine phosphorylation, rather than serine and threonine phosphorylation, is a characteristic feature of insulin and growth factor activity. Insulin binding to its transmembrane receptor (Fig. 12.7) stimulates aggregation of receptors and promotes tyrosine kinase activity in the intracellular domain of the receptor. The insulin receptor kinase activity autophosphorylates its tyrosine residues, enhancing its protein tyrosine kinase activity and phosphorylating tyrosine residues in other intracellular effector proteins, which then activate secondary pathways. Among these are kinases that phosphorylate serine and threonine residues on proteins, but at sites and on proteins distinct from those phosphorylated by PKA and PKC. Insulin-dependent activation of GTPase, phosphodiesterase and phosphoprotein phosphatases also checks the action of glucagon, which is typically present at high concentration in the blood at mealtimes, i.e. several hours since the last meal.
Body_ID: P012034
The liver also appears to be directly responsive to ambient blood glucoseView drug information concentration, increasing glycogen synthesis following a meal, even in the absence of hormonal input. Thus, the increase in hepatic glycogenesis begins more rapidly than the increase in insulin concentration in blood, and perfusion of liver with glucoseView drug information solutions in vitro, in the absence of insulin, also leads to inhibition of glycogenolysis and activation of glycogenesis. This appears to occur by direct allosteric inhibition of phosphorylase by glucoseView drug information and secondary stimulation of protein phosphatase activity.
Body_ID: P012036
Most, if not all, cells in the body are responsive to insulin in some way, but the major sites of insulin action, on a mass basis, are muscle and adipose tissue. These tissues normally have low levels of cell-surface glucoseView drug information transporters, restricting the entry of glucoseView drug information - they rely mostly on lipids for energy metabolism. In muscle and adipose tissue, insulin-receptor tyrosine kinase activity induces movement of glucoseView drug information transporter-4 (GLUT-4) from intracellular vacuoles to the cell surface, increasing glucoseView drug information transport into the cell. The glucoseView drug information is then used in muscle for synthesis of glycogen, and in adipose tissue to produce glyceraldehyde 3-phosphate which is converted to glycerol 3-phosphate for synthesis of triglycerides (Chapter 15).
Body_ID: P012037
Previous section
Bar end Bar end
Next section
Copyright © 2007 Elsevier Inc. All rights reserved. Read our Terms and Conditions of Use and our Privacy Policy.
For problems or suggestions concerning this service, please contact: studentconsult.help@elsevier.com